MAKE PROTECTION YOUR SUPERPOWER
Protect your patients who have cardio, renal, and metabolic conditions.
Shorts
Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)
Clinical relationship between the heart and the kidneys
Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)
Why is empagliflozin now a preferred heart failure treatment, coming from a history of diabetes?
Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)
How has recent evidence and the ESC 2023 guidelines changed management of heart failure?
Upcoming Events
PRIME SUMMIT 2 From screening to protection: Advancing cardiorenal metabolic care with SGLT2 inhibitors
Past Events
Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)
The heart failure patient through a holistic lens (Full)
Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)
The heart failure patient through a holistic lens (Summary)
Subodh Verma (Canada) | Soo Yong Lee (Korea)
